Fundraising Fox

Joris De Maeyer

Investor

Investor at Bioqube Ventures

Antwerp, Belgium

Writes $100K – $5M checks · typically $1.5M

About

Joris joined Bioqube Ventures in 2016 as Investment Director before becoming an Entrepreneur in Residence, advising the investment team and portfolio companies. He brings over 20 years of pharma and biotech experience, including roles as CEO/CSO of Facio Therapeutics and senior R&D positions at Johnson & Johnson, Movetis, and Shire. He holds a PhD in Medical Sciences from Ghent University and an MSc in Bioengineering from KU Leuven.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Temmune TherapeuticsChief Executive Officercurrent2026 — present
  2. Temmune TherapeuticsChief Operations Officer - COO2024 — 2025
  3. Invigo TherapeuticsFoundercurrent2023 — presentBelgium
  4. Bioqube VenturesExecutive in Residencecurrent2023 — present
  5. Bioqube VenturesInvestment Director2020 — 2023
  6. Bioqube VenturesVenture Coach2016 — 2020
  7. Anavo Therapeutics BVBoard Observercurrent2021 — present
  8. LIFE of SCIManaging Director - Life Science Consultingcurrent2013 — presentBelgium
  9. Facio TherapiesChief Executive Officer2021 — 2022
  10. Facio TherapiesActing Chief Executive Officer2021
  11. Facio TherapiesChief Scientific Officer2019 — 2021
  12. Facio TherapiesDirector R&D2014 — 2019
  13. ShireDirector Discovery2011 — 2013Belgium
  14. MovetisManager Drug Discovery & Development2007 — 2010Belgium
  15. Johnson & JohnsonScientist Drug Discovery2002 — 2006Belgium
  16. Johnson & JohnsonSenior Associate Preclinical Development (GLP DMPK TOX QA)2001 — 2002Belgium
  17. Vlaamse Milieumaatschappij - VMMAuditor Surface Water Monitoring Network2001
  18. KU LeuvenResearch associate2000 — 2001

Skills & more

Lifesciences15Pharmacology34Drug Discovery31Biotechnology18Drug Development23Pharmaceutical Industry10CRO6R&D5Life Sciences7

From Joris's professional profile.

Colleagues at Bioqube Ventures

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures

Network4

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures

Investors connected to Joris in public investor directories — a warm-intro map.

Frequently asked questions

Who is Joris De Maeyer?
Joris joined Bioqube Ventures in 2016 as Investment Director before becoming an Entrepreneur in Residence, advising the investment team and portfolio companies. He brings over 20 years of pharma and biotech experience, including roles as CEO/CSO of Facio Therapeutics and senior R&D positions at Johnson & Johnson, Movetis, and Shire. He holds a PhD in Medical Sciences from Ghent University and an MSc in Bioengineering from KU Leuven.
Where does Joris De Maeyer work?
Joris De Maeyer is Investor at Bioqube Ventures.
What does Joris De Maeyer invest in?
Joris De Maeyer invests in Biotech.
What check size does Joris De Maeyer write?
Joris De Maeyer typically writes checks of $100K – $5M.
Where did Joris De Maeyer go to school?
Joris De Maeyer studied at Ghent University (PhD, Medical Sciences); KU Leuven (Master's degree, Master in Engineering in Cell and Gene Biotechnology); Vrije Universiteit Brussel (Business and Biotechnology).

Same school

Also attended Ghent University87

Sabine VermassenExecutive Director at Capricorn Venture PartnersNoé WachsmuthVisiting Analyst at Capricorn Venture PartnersJeroen Van IseghemInvestment Analyst at Capricorn Venture PartnersLukasPartner at Hummingbird VenturesRoxanneCompliance Officer at Hummingbird VenturesSriram BalusuAssociate at Ysios Capital

+ 81 more

Also attended KU Leuven176

Katrin GeyskensExecutive Director at Capricorn Venture PartnersSimon WoutersInvestment Manager at Capricorn Venture PartnersSteven LambertInvestment Partner Digital at Capricorn Venture PartnersAntoine D'HollanderInvestment Director at Capricorn Venture PartnersWouter Van de PutteInvestment Director at Capricorn Venture PartnersFilip PintelonInvestment Partner Health at Capricorn Venture Partners

+ 170 more

Also attended Vrije Universiteit Brussel28

Kris VerburghPartner & Head of Science at BOLD LongevityAnne Cathrine WilhjelmAttorney, Partner at SEED Capital DenmarkKris VerburghPartner BOLD Longevity at Bold Capital PartnersYuhua BaiAccounting Officer at Astanor VenturesFilip KegelsOperational Partner at Astanor VenturesRuben PauwelsInvestor at Angelwise

+ 22 more

Shared employers

Also worked at Temmune Therapeutics2

Roderick VerhelstPrincipal at Bioqube VenturesTom HeymanExecutive Partner at Bioqube Ventures

Also worked at Bioqube Ventures15

Debora DumontManaging Partner at Bioqube VenturesDirk ReynManaging Partner at Bioqube VenturesNico VandervelpenManaging Partner at Bioqube VenturesJoris VanderlochtChief Scientific Director at Bioqube VenturesAlexander DemoulinAssociate at Bioqube VenturesRoderick VerhelstPrincipal at Bioqube Ventures

+ 9 more

Also worked at Shire13

Sun AltbachSenior Scientific Advisor at BOLD LongevityJulie KimRepresentative Director – President and CEO at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSun AltbachSenior Advisor BOLD Longevity at Bold Capital Partners

+ 7 more

Also worked at Johnson & Johnson151

Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture PartnersBrad H. ValeFounding General Partner at Treo Ventures, Llc

+ 145 more